glp 1 agonist diabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome DPP4 Inhibitors vs GLP-1 Agonists
Description
C., Mallory, J., & Home, P
On one hand, the confidence intervals only allow for conclusions regarding non-inferiority, and on the other hand, the average duration of observation was only 1 year
Use with caution in patients with renal or hepatic impairment
Tirzepatide is the first in a class of drugs called dual GLP-1/GIP receptor agonists that activate the receptor for another gut hormone, glucose-dependent insulinotropic polypeptide (GIP), in addition to the GLP-1 receptor
I am not given up my *affiliated* PCP over this, which is why I am trying the endocrinology route
